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ABSTRACT
Cell migration is a key characteristic o f embryogenesis, inflammation, wound
healing, tumor cell metastasis and a broad range o f other normal and pathological
processes. Accumulating evidence suggests that the protein tensin provides a physical
link between transmembrane receptors, proteins commonly associated with signal
transduction, and the actin cytoskeleton. Adhesion involves three broad classes o f
macromolecules: ExtraCellular Matrix (ECM) molecules, transmembrane adhesion
receptors, and intracellular adhesion plaque proteins. Tensin is particularly enriched in
Fibrillar Adhesions (FA’s), though it is also present to a modest extent in Focal Contacts
(FC’s).

Src Homology 2 (SH2) domains function in the transmission o f molecular

signals that start at the cell surface, pass through the plasma membrane, and engage the
inner workings o f the cell. SH2 domains carry out their function by binding with high
affinity to phosphotyrosine-containing protein targets in a sequence-specific and largely
phosphorylation-dependent manner. In this work, SH2 domain o f protein tensin, a
component o f cell-substrate contacts with close connections to cancer is used as an
investigative tool, to view the scientific problem from the perspective o f a biophysicist.
Recombinant DNA technology was used to clone the SH2 gene and overexpress
the recombinant SH2 domain. Molecular biology techniques like Sodium Dodecyl
Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE), immunblot analysis were used
to identify and characterize the protein molecular mass. Circular Dichroism (CD)

iii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

spectroscopy was used to determine the secondary structure o f the protein and to
demonstrate that the SH2 domain folds into a compact, stable molecule. Chemical
denaturation and heat denaturation studies were done using Differential Scanning
Calorimetry (DSC) to determine the thermostability o f the SH2 domain. These studies
reveal that the tensin-SH2 domain is highly stable as compared with some other known
SH2 domains. Detailed knowledge o f the structure and function o f tensin will accelerate
acquisition o f more detailed knowledge o f other focal adhesion components, advancing
the development o f molecular models o f cell attachment and migration. Such knowledge
is o f interest to basic science as well as medicine. Moreover, it could also provide a
model for nanotechnology development, providing inspiration for the design o f novel
types o f molecular recognition and functionality, and materials design and fabrication.
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CHAPTER 1
INTRODUCTION
1.1. Biology
1.1.1. Cell Migration
Cell migration is a key characteristic o f embryogenesis, inflammation, wound
healing, tumor cell metastasis and a broad range o f other normal and pathological
processes (Douglas et al., 1996; Alberts et al., 1994). Distinctive features o f cell
migration are polarization o f cell shape, extension o f the membrane, formation o f cellsubstratum attachments, generation o f contractile force and traction, and release from
attachment (Douglas et al., 1996).

Migration is influenced, regulated, or directly

switched on or off by changes in growth factor concentration, ExtraCellular Matrix
(ECM) receptor binding avidity, and receptor-cytoskeleton interactions (Huttenlocher et
al., 1995; Duband et al., 1991; Kassner et al., 1995). Accumulating evidence suggests
that the protein tensin provides a physical link between transmembrane receptors,
proteins commonly associated with signal transduction, and the actin cytoskeleton.
Tensin was first identified as a barbed-end actin capping protein immunolocalized at
various adherens junctions and Z-lines o f muscle (Wilkins et al., 1986).

1
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1.1.2. Cell Adhesion
Adhesion involves three broad classes o f macromolecules: extracellular matrix
(ECM) molecules, transmembrane adhesion receptors, and intracellular adhesion plaque
proteins. Cell adhesion plays a crucial part in regulating embryonic development, tissue
architecture, tissue function, and transmembrane signaling (Abercrombie et al., 1975;
Burridge et al., 1988; Walton et al., 1993; Jockush et al., 1995; Craig et al., 1996).
Adhesion o f any type o f adherent cell is characterized by three common features:
mediation by transmembrane ECM receptors called integrin, involvement o f the actin
cytoskeleton, i.e. microfilaments, and involvement o f a complex assembly o f anchoring
proteins (Critchley, 2000; Jockusch et al., 1995; Yamada and Geiger, 1997). Integrins
enable the cell to form close contacts with the ECM. Adhesion Complexes (AC’s) are
structurally and functionally diverse (Zamir et al., 1999, 2001). Two types o f A C ’s seen
in cultured fibroblasts are Focal Contacts (FC’s) and Fibrillar Adhesions (FA’s). FC ’s are
found mainly at the cell periphery, and FA ’s more in the center o f the cell. The detailed
molecular compositions o f these structures are quite different, as are their functions and
dynamics. Tensin is particularly enriched in FA ’s, though it is also present to a modest
extent in FC ’s (Zamir et al., 2000). Figure 1.1 shows a schematic diagram o f an adhesion
complex.
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Figure 1.1. Interactions Between the Cytoplasmic Tails o f Integrin and Cytoskeletal
Proteins Provide a Physical Link Between the Actin Cytoskeleton and the ECM. Vuori,
K. (1998). Journal o f Membrane Biology 165: 191-199.

A C’s have at least two significant cellular functions: to transmit force or tension
at adhesion sites and to serve as signaling centers from which numerous intracellular
pathways emanate. The former helps a cell maintain strong attachments to the underlying
ECM, and the latter plays a role in the regulation o f cell growth and gene expression
(Jockush et al., 1995; Abercrombie et al., 1975; Burridge et al., 1988). AC’s have been
identified in various cell types o f cellular structures: living and fixed fibroblasts cultured
in vitro on glass or plastic, myotendinous Z-junctions o f skeletal muscle, adherent
epithelial and endothelial cells, activated blood platelets, and structures called podosomes
(Jockush et al., 1995; Abercrombie et al., 1975; Burridge et al., 1988).
A C’s are dynamic structures that can be assembled, dispersed, and recycled as
cells migrate or enter into mitosis. Two stages in AC formation and maturation have

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

been identified: formation o f initial or immature focal adhesions (Bershadsky et al., 1985;
Izzard, 1998; Izzard and Lochner, 1980; Izzard and Izzard, 1987), also called focal
complexes, and maturation o f focal adhesions (Bershadsky et al., 1985). Alteration o f the
structure and composition o f A C’s during cell migration is thought to play a role in cell
attachment and detachment. Large-scale reorganization o f AC’s during the cell cycle or
neoplastic

transformation

morphological changes.

correlates

with

loss

of

adhesion

and

concomitant

Aberrant changes in the activities o f protein kinases and

phosphatases at A C ’s may lead to a number o f diseases, including cancer (Ishida et al.,
1995). A C’s thus may be important for tumor suppression.
There are two general patterns o f ECM reorganization in cultured fibroblasts. In
one, tensin-containing FC ’s move slowly, along the cell margin. In the other, dynamic
tensin-rich FA ’s are found closer to the cell center. FA ’s can also translocate laterally,
but they contain little phosphotyrosine (pTyr or pY). FA ’s are described as elongated or
beaded, mirroring association with fibronectin fibrils. They are enriched in 0 :5/81 integrin
and tensin (Zamir et al., 2000). They are found < 100 nm from the substrate; interact
with fibronectin fibrils, migrate slowly, and play a role in assembly o f the fibronectin
matrix.

Geiger et al. (1995) have proposed that FA formation depends on ECM

reorganization and segregation o f cellular components from FC’s. Studies o f the ECM
have shown that in primary fibroblasts,

0:5181

integrin associates with fibronectin fibrils,

forming FA sites containing an enriched quantity o f tensin but a low level o f other
common FC elements, e.g. paxillin, vinculin, and tyrosine-phosphorylated proteins
(Zamir et al., 2000). Fibronectin promotes formation o f FC’s when covalently linked to
the substrate, indicating that cytoskeletal organization and phosphorylation at FC ’s
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depends on physical properties o f the ECM (Zamir et al., 2000). Other details o f the
complex formed among integrins and their extracellular ligands and appropriate
cytoplasmic anchor proteins may regulate the local tension o f a FC, activate tyrosine
phosphorylation, and promote formation o f various types o f matrix adhesion in
fibroblasts (Zamir et al., 2000).
The transmembrane receptor molecules called integrins have a short cytoplasmic
tail region apparently devoid o f enzymatic activity. The interaction o f integrins with their
ligands enables cell adhesion. This interaction may trigger signaling responses but does
not generally induce the formation o f focal complexes. Integrin clustering may induce
association with intracellular scaffolding proteins that play a key role in signaling. A
focal complex is apparently a nascent adhesion site, the transformation depending on
appropriate external stimuli or intracellular signaling. The assembly o f focal adhesions is
regulated by the GTP-binding protein Rho. Rho stimulates contractility which, in cells
tightly adherent to the substrate, generates isometric tension. This tension leads to the
bundling o f actin filaments and the aggregation o f integrins in the plane o f the membrane.
The aggregation o f integrins activates the focal adhesion kinase (FAK) and leads to the
assembly o f a multicomponent signaling complex (Burridge and ChrzanowskaWodnicka, 1996).The structural dynamics o f a focal adhesions are governed by heat
exchange with the local environment and changes in rate constants regulated by
phosphorylation and other types o f adhesion promoting stimuli.
FA assembly is triggered by ligation o f integrins by the ECM.

This process

includes activation o f a cascade o f intracellular signaling events involving tyrosine
kinases and GTPase Rho-A , and phosphorylation o f cytoskeletal substrates which results
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in cell migration, a highly-integrated macroscopic biological process.
develop from one pole o f FC ’s.

FA ’s appear to

The FA translocation process depends on an intact

microfilament system and active myosin II.
FC formation requires integrins and other membrane-associated proteins being
directed rapidly toward the cell periphery, including the leading edge and integrin
clustering.

These proteins tend to remain in place after this clustering.

Proteins

involving multiple binding domains enable molecular interconnections to be enhanced,
modified, or linked to signaling pathways.

The physical properties o f these

interconnections, such as their response to and ability to transmit mechanical forces, are
almost certainly governed by signal-induced chemical modifications and are linked to be
a key aspect o f regulation o f migration. Tensin is recruited early in the process o f FC
assembly (Miyamoto et al., 1995).
Tensin-containing fibrils emerge from the medial ends o f FC’s and translocate
towards the cell center. Such short tensin structures can merge with each other to form
FA ’s, containing little or no paxillin, vinculin, and FAK or pTyr.
1.1.3. Protein Phosphorylation
in Cell Adhesion
Reversible phosphorylation o f proteins is a ubiquitous mechanism o f control o f
intracellular signal transduction pathways.

Phosphorylation can be triggered by

extracellular effectors such as hormones, mitogens, and cytokines, and by nerve
impulses. Such processes as metabolism, gene expression, cell division, differentiation,
development, transport, and locomotion are regulated at least in part by the
phosphorylation and resultant activation or inactivation o f proteins in critical biochemical
pathways.

Protein phosphorylation thus constitutes the molecular basis o f control o f
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numerous complex physiological events within cells. In some cases control is achieved
by phosphorylation on a specific amino acid; the assembly o f multi-protein complexes
can be directly regulated by the recruitment o f phospho-specific binding modules. The
level o f tyrosine phosphorylation o f a given protein in vivo is regulated by the opposing
actions o f Protein Tyrosine Kinases (PTK’s), Protein Tyrosine Phosphatases (PTP’s), and
Dual-Specificity Phosphatases (DSP’s). PTP’s and in some cases D SP’s are hydrolytic
enzymes that catalyze removal o f the phosphoryl group o f a specific phosphotyrosine,
phosphoserine

(pSer)

or

phosphothreonine

(pThr)

from

a

specific

substrate

macromolecule.
Formation o f adhesive structures in cells is strongly correlated with covalent
modification o f proteins by tyrosine phosphorylation. Various cytoskeleton-associated
proteins are phosphorylated on tyrosine on cell adhesion to a substratum or extension o f a
filopodium.

The most prominent and best characterized o f these phosphoproteins are

FAK, paxillin, and tensin (Otey et al., 1993; Pavalko et al., 1993, Schaller et al., 1995,
Guan et al., 1991; Komberg et al., 1991; Burridge et al., 1992; Bockholt and Burridge,
1993). These proteins are key players in the formation o f FC’s, and they are the earliest
adhesion-related proteins to undergo phosphorylation (Pfaff et al., 1998). v-Src induced
tyrosine phosphorylation on tensin and other FC proteins is reduced when cell-substratum
adhesion is lost (Sabe et al., 1997).
FAK, a particularly interesting and well-studied component o f FC ’s, binds talin
and vinculin via its Carboxyl-terminus (C-terminus), and the /3 subunit o f integrin by its
Amino-terminus (N-terminus). Once bound to other focal adhesion components, FAK
autophosphorylates on Tyr 397 and binds the SH2 domain o f Src. FAK phosphorylates
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numerous proteins on different tyrosine residues. In addition to an SH2 site, FAK also
has binding sites for structural proteins such as paxillin, talin, and integrin (Pavalko et al.,
1993, Calderwood et al., 1999, Hannigan et al., 1996).

Tensin, known to become

phosphorylated during FA assembly, may be a substrate o f FAK. Tensin could also be a
binding partner o f Src. Recruitment o f Src to the developing FA may be responsible for
recruitment o f tensin; phosphorylation o f tensin may be involved in the regulation o f a
FA. Another key point o f FAK is self-regulation through independent expression o f a
portion o f the FAK gene (Richardson et al., 1996).
Inhibitors o f tyrosine phosphorylation inhibit phosphorylation o f FC components
and correspondingly diminish the ability o f a cell to migrate or spread (Loo et al., 1998).
Phosphorylated tyrosine residues in FAK, paxillin, tensin and other FC proteins, along
with other binding sites in these proteins, are likely play key roles in the assembly o f
FC ’s.
This discussion on protein phosphorylation o f FA proteins is particularly relevant
to a complete description o f tensin structure and function, because amino acid sequence
comparisons have revealed that tensin has several phosphotyrosinyl recognition modules.
Fibroblast tensin is phosphorylated on tyrosine, serine, and threonine, with tyrosine
phosphorylation increasing on oncogenic transformation and growth factor stimulation
(Davis et al., 1991).
1.1.4. Tensin
1.1.4.1. Introduction
The large 220 kDa, cytoskeleton-associated docking protein tensin was first found
in adhesive junctions o f animal cells (Wilkins et al., 1986), including Z lines in skeletal
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muscle. Tensin derived its name from its putative role in anchoring actin filaments to
focal adhesion sites. Thus it maintains tension in the focal adhesion sites and enables cell
migration. It is recruited early in the development o f cell-substrate contacts (Miyamoto et
al., 1995), where it binds the cytoplasmic domain o f integrin f t (Calderwood et al., 2003)
and caps the barbed ends o f filamentous actin (Chuang et al., 1995). The N terminus o f
tensin is a close homolog o f a protein with phosphatase homology and tensin homology
(PTEN) (Figure 1.3), known to be an established tumor suppressor (Li et al., 1997). A
model o f tensin in focal adhesions is shown in Figure 1.2.

F-actin
SH2 PTB

PTP

Integrin
p subunit
a subunit

Figure 1.2. M olecular Model o f Interaction o f Tensin with Other Focal Adhesion
Components, Including the Plasma Membrane.

Tensin is found in numerous eukaryotic organisms, including humans and
nematode worms. The latter have but c. 1,000 cells at adulthood. In H. sapiens tensin
has been mapped to chromosome 2 (locus ^35-36). A second transcript o f this gene has
been described, but its full-length nature has not been determined (Lo et al., 1994a).
Tensin is a substrate o f calpain II, an FA protease involved in the assembly and
disassembly o f FC ’s. Some biochemical properties o f tensin are given in Table 1.1.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10

Table 1.1. Synopses o f Properties o f Tensin
Property

References

Localized at:
Focal adhesion sites in cultured fibroblasts

Wilkins and Lin (1986)

Dense plaques in smooth muscle

North etal., (1993)

Neuromuscular junctions, myotendinous junctions
sarcolemma o f skeletal muscle

Bockholt et al., (1992), North
etal., (1993)

Present in low abundance in cultured fibroblasts and
other cell types

Wilkins and Lin (1986)

Highly sensitive to proteolysis
Difficult to purify
Recruited to focal adhesion sites by a5(3\ integrin
aggregation

Wilkins and Lin (1986)
Wilkins and Lin (1986)
Miyamoto et al., (1995),
Pankov et al., (2000)

Newly expressed (along with FAK) in granulation
tissue myofibroblasts in a type o f focal adhesion
involving extracellular fibronectin and stress fibers
that contain a-smooth muscle a -actin
Normal muscle development in tensin -/- mouse

Dugina et al., (2001)

Not necessary for embryogenesis in mice, but
possibly required for normal renal function in adults

Lo et al., (1997)
Lo et al., (1997)

Phosphorylated on serine and threonine
Davis et al., (1991)
Increased phosphorylation on tyrosine from:
Spreading o f fibroblasts following attachment to Bockholt and Burridge (1993)
ECM
Treatment o f certain cell types with platelet- Jiang et al., (1996), Ishida et
derived growth factor, thrombin, or angiotensin
al., (1999)
Transformation o f certain cell types with v-src or Davis et al., (1991), Salgia et
bcr/abl
al., (1995)
PI losphorylated by protein kinase C, cdc2 kinase, Lo et al., (1994b)
F.AK, epidermal growth factor receptor, and Src in
VItro
Middle region o f polypeptide inhibits actin Chuang et al., (1995), Lo et
polymerization by capping with the barbed end o f al., (1994c)
filaments
May also cross-link actin filaments
Chuang et al., (1995), Lo et
a l..n 9 9 4 c l
Substrate o f calpain II, a calcium-regulated focal Chen et al., (2000)
adhesion protease
Contains large number o f PEST regions

Chuang et al., (1995)

SH2 domain identified near C-terminus

Davis et al., (1991)
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SH2 domain can interact with certain tyrosinephosphorylated proteins, notably PI3K and pl30C as

Salgia et al., (1995), Auger et
al., (1996)

PTP domain that is non-catalytic identified at Nterminus

Haynie and Ponting (1996)

Identified as close homo log o f PTEN

Steck et al., (1997), Li et al.,
(1997)

PTB domain identified at C-terminus

Haynie and Ponting (personal
communication, 1997)
Lee et al., (1999)
Haynie and M. Humphries
(unpublished data,
1998),
Margolis (1999)
Chen and Lo (2003)

C2 domain identified near N-terminus
PTB domain binds integrin /31

Both N- and C-terminal domains required to promote
cell migration

There are three regions in the full-length polypeptide: N-terminus, central region,
C-terminus. Three signal transduction-related domains have been identified in tensin: a
Protein Tyrosine Phosphatase (PTP) domain, a Src Homology 2 (SH2) domain and a
PhosphoTyrosine Binding (PTB) domain.

Protein tyrosine phosphorylation

and

dephosphorylation is crucial for cell growth, tissue differentiation, inter-cellular
communication, and the immune response. Tensin also contains a C2 domain, the
function o f which is not known. The domain architecture o f human tensin is shown in
Figure. 1.3. The actin-binding region was determined in vitro by actin-binding assays.

Phosphoryl-recognition m odules
A ctin-cajping region

y

J V

PTEN-homolog

V
Proline rich

Figure 1.3. Putative Domain Architecture o f Tensin. “Y” and “Z” are Putative Domains
(D.T.Haynie, Unpublished Results, Permitted by D.T.Haynie).
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SH2, PTP, and PTB domains recognize phosphotyrosine (or some other
phosphorylated chemical group). It might also be true o f the C2 domain in tensin (Lee et
al., 1999).

These four domains were identified in tensin by amino acid sequence

comparisons.
domains

They are likely to be independently thermostable.

individually

and

corporately

implicates

tensin

in

Each o f the known
intracellular

signal

transduction.
PTP-C2 is the molecular architecture o f PTEN/MMAC1 (phosphatase and tensin
homo log deleted on human chromosome

10

or mutated in multiple advanced cancers), a

protein o f considerable current interest (Li et al., 1997; Steck et al., 1997). PTPs and
D SP’s have the same fold.

This similarity suggests that the tensin PTP domain will

recognize phosphotyrosine, phosphoserine, phosphothreonine or, in view o f the activity
o f PTEN, some form o f phosphatidylinositol. SH2 domains can bind phosphotyrosines
o f activated tyrosine kinase receptors, their substrates, and other proteins (Walton et al.,
1993). The PTB domain will recognize phosphorylated tyrosine in its target. Similarity
to the PTB domain o f Src homologous and collagen (She) suggests that tensin may bind
specifically to a transmembrane receptor. Basic structural properties o f the actin-binding
region o f tensin, identified by biochemical assays, have not yet been determined.
Research on the molecular physiology o f tensin involves analysis not only o f interactions
between a modular binding domain o f tensin and its targets in other proteins, but also
intramolecular interactions in tensin. Domain alignments o f some tensin homologs are
shown in Figure 1.4.
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Figure 1.4. Domain Architecture o f Tensin-like Proteins (D.T. Haynie, Unpublished,
Permitted by D.T. Haynie).

Human tensin2 cDNA encodes a 1,285 amino acid sequence that shares extensive
homology with tensin 1 at its amino- and carboxyl-terminal ends, which include the actinbinding domain, the Src homology 2 (SH2) domain, and the phosphotyrosine binding
(PTB) domain. Analysis o f the genomic structures o f tensinl and tensin2 further
confirmed that they represent a single gene family. Examination o f tensin2 mRNA
distribution revealed that heart, kidney, skeletal muscle, and liver were tissues o f high
expression. The endogenous and recombinant tensin2 were expressed as a 170-kDa
protein in NIH 3T3 cells. The subcellular localization o f tensin2 was determined by
transfection o f Green Fluorescence Protein (GFP)-tensin2 fusion construct. The results
indicated that tensin2 is also localized to focal adhesions. Finally, functional analysis o f
tensin genes has demonstrated that expression o f tensin genes can promote cell migration
on fibronectin indicating that the tensin family plays a role in regulating cell motility
(Chen et al., 2002).
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1.1.4.2 Carboxyl terminus of tensin
Tensinl is an actin-binding protein localized to focal adhesions (Lo et al., 1994),
which play a crucial role in many biological events such as cell adhesion, migration,
proliferation, differentiation, and apoptosis. The N-terminus o f tensinl binds to actin
filaments (Lo et al., 1994), whereas the center region retards the G-actin polymerization
(Lo et al., 1994). The C-terminus contains the SH2 (Davis et al., 1991) and the PTB
domain. In addition, tyrosine phosphorylation o f tensinl is enhanced by extracellular
matrix, growth factors, or oncogenes (Bockholt et al., 1993, Jiang et al., 1996, Salgia et
al., 1995). Tyr phosphorylation o f tensinl suggests that tensinl plays important roles in
organizing actin cytoskeleton and mediating signal transduction (Lo et al., 1994a). Chen
et al. (2002) have shown that expression o f tensinl promotes cell migration. Furthermore,
analysis o f tensinl knockout mice has demonstrated a critical role o f tensinl in renal
function and wound healing (Lo et al., 1997, Ishii et al., 2001). Because the tissuerestricted phenotypes found in tensinl knockout mice were unexpected because o f
tensin’s broad expression pattern, Chen et al. (2002) decided to search for other family
member(s) and reported the identification o f tensin2 (Chen et al., 2002). Human tensin2
contains 1285 amino acid residues and shares extensive homology with tensinl at its bl
and C-terminal ends, although the center portions o f the molecules are divergent. The
homologous regions span the Albumin-Binding Domain (ABD), the SH2 domain, and the
PTB domain. Functional analysis also indicates a conserved role o f tensin2 in cell
migration. A recent study reported the cDNA sequence and the genomic structure o f a
more distant member o f the tensin family, Carboxyl terminal tensin-like (cten) protein. In
contrast to tensinl and tensin2, Cten is a shorter polypeptide and is preferentially
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expressed in prostate and placenta. To date, Cten is the first and only focal adhesion
molecule that is specifically expressed in prostate gland. Interestingly, expression o f Cten
is down-regulated in prostate cancer, suggesting that Cten may be involved in prostatic
cell transformation and may have a potential use in disease diagnosis and prognosis
during treatment (Chen et al., 2002).
1.1.4.3. SH2 domain
1.1.4.3.1. Evolution of SH2 domain
The evolution o f multicellular animals appears to be coincident with the
development o f the unique signaling m otif called the SH2 domain. SH2 domains have
thus far been found only in animals and viruses and apparently do not occur in fungi or
plants (Branden et al., 1999). The name comes from its being discovered in the genomes
o f Sarcoma (Src) viruses. Similar sequences were later found in many other intracellular
signal-transducing proteins.

SH2 domains function in the transmission o f molecular

signals that start at the cell surface, pass through the plasma membrane, and engage the
inner workings o f the cell. SH2 domains can fold independently into a compact, stable
structure like most other domains. The SH2 domain in human tensin corresponds to
residues 1463 to 1557; it is located near the C-terminus.
1.1.4.3.2. Function of SH2 domain
SH2 domain was first identified as a conserved sequence domain between the
oncoproteins Src and Fps. Similarly conserved sequences were subsequently found in
many other intracellular signal transducing proteins. More specifically, SH2 domains are
regulatory modules o f intracellular signaling cascades. SH2 domains play a role in the
intracellular response to growth factor stimulation by binding to phosphotyrosine
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containing proteins (Charifson et al., 1997). SH2 domains carry out their function by
binding with high affinity to phosphotyrosine-containing protein targets in a sequencespecific and largely phosphorylation-dependent manner (Branden et al., 1999, Wandless
1996, Furga 2000).

The SH2 domain o f one protein binds to a second protein that

contains a phosphorylated tyrosine side chain in a specific amino-acid sequence context
(Furga 2000). In some cases, however, an SH2 domain can bind to the target protein or
ligand in a non-pTyr dependent manner (Forman-Kay et al., 1999). For instance, the
SLAM-Associated Protein (SAP) SH2 domain binds Signaling Lymphocytic Activation
Molecule (SLAM) (Li et al., 1999), and the Growth factor receptor bound protein 10
(GrblO) SH2 binds the C2 domain o f Nedd4 (Vecchione et al., 2003) in the absence o f
phosphorylation. Such non-pTyr dependent binding could also occur in tensin. The SH2
domain could possibly interact with the C2 domain o f the same tensin molecular or
another tensin molecule. Alternatively, the SH2 domain o f tensin could possibly interact
with a pTyr residue in the same tensin molecule (intramolecular association, as in Src) or
in another tensin molecule (intermolecular association, in this case dimerization).
A cross-sectional view o f an animal cell is shown in Figure 1.5, with the cell
membrane depicted in yellow. A hormone is bound by its specific transmembrane
receptor (both in red). Activation o f the receptor causes phosphorylation o f the tyrosine
(phosphotyrosine in green), which enables a signaling protein containing an SF12 domain
(purple) to recognize the receptor. The signaling protein contains a catalytic domain
(white), which transmits a signal when the SH2 domain is engaged. The SH2
phosphotyrosine interaction allows specific molecular pairings to be established in the
crowded environment o f the cell.
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Figure 1.5. Cross Sectional View o f an Animal Cell Depicting the Function o f SH2
Domain (Kuriyan et al., 1999).
The SH2 domain is a molecule that functions in protein-protein interactions. Its
binds the region containing it to a second regions that contains a phosphorylated tyrosine
side chain in a specific amino acid sequence context (Branden et al., 1999, Furga et al.,
2000). The SH2 domain fold includes a central beta stranded sheet and two alpha helices
on either side o f it.

In Src family SH2 domains, a hydrophobic pocket recognizes a

leucine or isoleucine residue at position pY+3 in high affinity peptides (Alberts et al.,
1994).
Proteins bind to other proteins through several types o f interface. Proteins can bind
to another protein in at least three ways: a portion o f the surface o f one protein contacts
an extended loop o f polypeptide chain on a second protein. Such an interaction allows the
SH2 domain o f a protein to recognize the phosphorylated polypeptide as a loop on second
protein. It also enables a protein kinase to recognize the proteins that it will
phosphorylate (Alberts et al., 1994). Two a helices, one from each protein, pair together
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to form a coil. This type o f interaction is found in several gene regulatory proteins. The
precise matching o f one rigid surface with that o f another occurs; this is the common type
o f the three. Such interaction can be tight because a large number o f weak bonds can
form between two surfaces that match well. This interaction is specific, enabling a
protein to select just one partner from thousands o f different proteins found in a cell
(Alberts et al., 1994).
I.I.4.3.3. Binding partners for SH2 domain
The SH2 domain is a compact plug-in molecule that can be inserted almost
anywhere in a polypeptide chain without disturbing other aspects o f protein folding or
function. Each domain has distinct sites for recognizing phosphotyrosine and for
recognizing a particular amino acid side chain; different SH2 domains recognize
phosphotyrosine in the context o f different flanking amino acid sequences. SH2 motifs in
certain cytoplasmic protein are crucial in the signaling pathways o f the tyrosine kinase
growth factor responses. Short, conserved motifs, primarily three to four amino acids on
the C-terminal side o f a phosphotyrosine residue, may carry the sequence-specific
information for SH2 recognition (Alberts et al., 1994, Wandless 1996).
Phosphopeptide libraries have been used to determine the sequence specificity o f
the peptide binding sites o f SH2 domains. One group o f SH2 domains (Src, Fyn, Lck,
Fgr, Abl, Crk, and Nek) prefer sequences with the general m otif pTyr-hydrophilichydrophilic-Ue/Pro while another group (SH2 domains o f C-y and SHPTP2) bind to the
general m otif pTyr-hydrophobic-X-hydrophobic. Individual members o f this group bind
to unique sequences, except the Src sub-family (Src, Fyn, Lck and Fgr), which all bind to
pTyr-Glu-Glu-Ile. The variability in SH2 domain sequences in likely sites o f contact
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provides a structural basis for the phosphopeptide selectivity o f these families (Charifson
et al., 1997). Subgroups o f SH2 domain and their known ligands are given in Table 1.2.

Table 1.2. SH2 Family and Their Ligand Binding Partners
Subgroups o f SH2 domain

Amino acid sequence o f binding partner

Src, Fyn, Lck, Fgr, Abl, Crk, Nek

p Y-hydrophilic-hydrophilic-I/P

p 8 , phospholipaseC-gamma, and SHPTP2

p Y-hydrophobic-X-hydrophobic

Src sub family ( Src, Fyn, Lck, Fgr)

pY-E-E-I

1.1.4.3.4. Structure determination of tensin-SH2
domain and comparison with other
known SH2 domains
The function o f a protein is determined by its structure, which in turn is
determined by the sequence o f amino acids in the polypeptide. Several approaches could
be used to determine the structure o f tensin-SH2 domain. One o f them was to determine
the secondary structure o f tensin-SH2 domain and compare it with the secondary
structures o f other known SH2 domains. The other was to determine if the tensin-SH2
domain is stable on its own and if it folds independently o f the upstream or downstream
part o f the protein. Also, the tensin-SH2 domain could be modeled using softwares like
CharmM, based upon the available knowledge o f the crystal structures o f other SH2
domains.
Protein structures have been divided into four classes on the basis o f their
secondary structures: (a), containing only a-helices; (j8 ), containing primarily /3-sheet
structure; (a + /3), containing helices and sheets in different parts o f the structure; and
(o//3), in which helices and sheets interact and often alternate along the polypeptide chain.
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In (a) proteins, about 60% o f the residues are in a-helices, and the helices are usually in
contact with each other. In (/3) proteins, there are always two /3-sheets, both usually anti
parallel that pack against each other. In the (a + (3) proteins, there may be a single /3 sheet,
usually antiparallel; the helices often cluster together at one or both ends o f the 18 sheet.
SH2 domains are known to be a part o f (a + (3) structure class. The (c^/3) proteins have
one major /3-sheet o f primarily parallel strands; a helix usually occurs in each o f the
segments o f polypeptide chain connecting the /3-strands, probably owing to the
necessarily long lengths o f these connections. The helices pack on both sides o f the sheet
unless the sheet is closed into a barrel, in which case the a-helices pack around outside o f
the barrel.

1.2. Methodology
1.2.1. Recombinant DNA Technology
Recombinant DNA (rDNA) has various definitions, ranging from simple to
strangely complex. The following are examples o f how recombinant DNA is defined:
1.

A DNA molecule containing DNA originating from two or more sources.

2.

DNA that has been artificially created. It is DNA from two or more sources
that is incorporated into a single recombinant molecule.

3.

According to the NIH

guidelines, recombinant DNA

are molecules

constructed outside o f living cells by joining natural or synthetic DNA
segments to DNA molecules that can replicate in a living cell, or molecules
that result from their replication.
Recombinant DNA, also known as in vitro recombination, is a technique involved
in creating and purifying desired genes. Molecular cloning (i.e., gene cloning) involves
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creating recombinant DNA and introducing it into a host cell to be replicated. One o f the
basic strategies o f molecular cloning is to move desired genes from a large, complex
genome to a small, simple one. The process o f in vitro recombination makes it possible to
cut different strands o f DNA, in vitro, with a restriction enzyme and join the DNA
molecules together via complementary base pairing.
1.2.2. Steps Involved in Making rDNA
The following is a summary o f the process o f making rDNA:
1.

Treat the DNA taken

from both sources with the same restriction

endonuclease.
2.

The restriction enzyme cuts both molecules at the same site.

3.

The ends o f the cut have an overhanging piece o f single-stranded DNA called
“blunt ends.”

4.

These blunt ends are able to base pair with any DNA molecule that contains
the complementary blunt end.

5.

Complementary blunt ends can pair with each other when mixed.

6.

DNA ligase is used to covalently link the two strands into a molecule o f
recombinant DNA.

7.

To be useful, the recombinant DNA needs to be replicated many times (i.e.
cloned). Cloning can be done in vitro, via the Polymerase Chain Reaction
(PCR), or in vivo using unicellular prokaryotes (e.g. E. coli), unicellular
eukaryotes (e.g. yeast), or mammalian tissue culture cells.
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1.2.3. Choice o f H ost O rganism
Among the many systems available for heterologous protein production, the
Gram-negative bacterium Escherichia coli remains one o f the most attractive because o f
its ability to grow rapidly and at high density on inexpensive substrates, its wellcharacterized genetics and the availability o f an increasingly large number o f cloning
vectors and mutant host strains. Although there is no guarantee that a recombinant gene
product will accumulate in E. coli at high levels in a full-length and biologically active
form, a considerable amount o f effort has been directed at improving the performance
and versatility o f this workhorse microorganism. Different types o f organisms and the
advantages and disadvantages o f each are listed in Table 1.3. Many additional details and
references can be found in Makrides’ (1996) review.

Table 1.3. Choice o f Host Organisms, W ith the Advantages and Disadvantages o f Each.
Disadvantages

Host

Advantages

Bacteria
e.g.
Escherichia coli

post
translational
Many references and much No
modification
experience available
Biological
activity
and
Wide choice o f cloning vectors
immunogenicity may differ
from natural protein
Gene expression easily controlled High endotoxin content in
gram negative bacteria
Easy to grow with high yields (
target protein can form upto 50%
o f total cell protein)
Product can be designed for
secretion into the growth media
Secretes target protein into the Does not express at high levels
as compared with E. coli
growth media

Bacteria
e.g.
Staphylococcus
aureus
Mammalian cells

Same biological activity as native
proteins
Mammalian expression vectors
are available
Can be grown in large scale

Cells can be difficult
expensive to grow
Cells grow slowly
Manipulated

cells
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cultures

Lacks detectable endotoxins

Yeasts

Fermentation less expensive and
facilitates
glycosylation
and
formation o f disulfide bonds
Cultured
insect Many processing systems similar
cells
to eukaryotic cells
Baculovirus vector Baculovirus
vector
FDA
approved for clinical trials
Virus
stops
host
protein
amplification;
high
level
expression o f target protein
Fungi
e.g.
Aspergillus sp.

Well established systems for
fermentation
for
filamentous
fungi
Growth inexpensive

genetically unstable and low
productivity as compared with
microorganisms.
Gene expression less easily
controlled
Glycosylation not identical to
mammalian systems
Lack
o f information
on
glycosylation mechanisms
Product not always fully
functional
Few
differences
between
functional
and
antigenic
properties between target and
native proteins
High levels o f expression not
yet achieved
Genetics
characterized

not

well

Can secrete large quantities o f
product into growth media,
source
o f many
industrial
enzymes
Low transformation efficiency
and long generation time

Plants

1.2.4. Plasmid
I.2.4.I. Introduction
Plasmids are small, circular, extrachromosomal DNA molecules found in bacteria,
which can replicate on their own, outside o f a host cell. They have a cloning limit o f 100
to 10,000 base pairs or 0.1-10 kilobases (kb). A plasmid vector is made from natural
plasmids by removing unnecessary segments and adding essential sequences. Plasmids
make excellent cloning vectors for various laboratory techniques, including rDNA.
Transformation is the modification o f the genotype o f a cell (usually prokaryotic)
by introducing DNA from another source. During transformation, genetic information is
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transferred via the uptake o f free DNA. Often these sources o f DNA come from plasmids
that are deliberately introduced into a cell, transforming the cell with its genes.
Transformation occurs naturally, and the resulting uptake o f foreign DNA by the cell is
not typically considered rDNA. If the plasmid being introduced to the cell has not been
genetically altered, in vitro, the plasmid is not considered to contain rDNA.
Plasmids that have been genetically altered, such as by the insertion o f an
antibiotic resistance gene, do contain rDNA because the original genetic composition o f
the plasmid has been artificially altered. These plasmids can be used to incorporate
bacterial cells with the antibiotic resistance gene via transformation.
I.2.4.2. Choice o f plasmid
To clone the gene o f interest, all engineered vectors have a selection o f unique
restriction sites downstream o f a transcription promoter sequence. The choice o f vector
family is governed by the host. Once the host has been selected, many different vectors
are available for consideration, from simple expression vectors to those that secrete
fusion proteins. However, as for the selection o f a suitable host system, the final choice o f
vector should take into consideration the specific requirements o f the application and
will, o f course, be influenced by the behavior o f the target protein. One key factor that
has led to the increased use o f fusion protein vectors is that amplification o f a fusion
protein containing a tag o f known size and biological function can greatly simplify
subsequent isolation, purification and detection. In some cases the protein yield can also
be increased. Table 1.4 reviews some o f the features o f fusion protein amplification that
may influence the final choice o f vector.
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Table 1.4. Advantages and Disadvantages o f Fusion Proteins Over Non-fusion Proteins
Advantages
Fusion proteins
Provide a marker for expression

Disadvantages

Tag may interfere with protein
structure and affect folding or
biological activity
Simple
purification
using
affinity Cleavage is not always 100%
chromatography under native or denaturing specific if tag needs to be removed
conditions
Easy detection
Refolding achievable on chromatography
column
Ideal for secreted proteins as the product is
easily isolated from growth media
Non-fusion proteins
Purification and detection not as
No cleavage steps necessary
simple
Problems with solubility may be
difficult to overcome, reducing
potential yield

1.3. Objectives
The short-term objectives o f this work are as follows: (1) to express and purify the
SH2 domain utilizing standard tools in molecular biology, (2) to assess the purity o f the
recombinant protein obtained using Capillary electrophoresis as a tool, (3) to calculate
the exact mass o f the SH2 domain using Mass spectrophotometer, and (4) to determine
the biophysical and biochemical properties o f this protein using circular dichroism
spectrophotometer and differential scanning calorimetry as investigative tools.
The long term objective o f this work is to use tensin as a tool to investigate to
elucidate the physiology o f cell substrate contacts at the molecular scale, and determine
the molecular basis o f focal adhesion and cell migration.
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1.4. Organization
Chapter One is introduction and literature review followed by the specific
objectives o f this work in Section 1.3. Chapter Two is materials and methods which
covers in some detail the various molecular biology and biophysical techniques used as
tools in this work. Results are presented in Chapter Three and Chapter Four is a
discussion which explains the significance and implications o f the results presented in the
preceding chapter. Chapter Five summarizes the work done with conclusions and
recommendations for further work to acquire more detailed knowledge about the SH2
domain o f tensin.
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CHAPTER 2
MATERIALS AND METHODS
2.1. Molecular Biology Techniques
2.1.1. Bacterial Transformation
2.1.1.1. Materials
2.1.1.1.1. Plasmid
The pET-14b plasmid vector (Novagen, USA) was used for gene cloning. A map
o f the plasmid is shown in Figure 2.1. The size o f PET-14b vector is 4671 bp with G-C
content o f 53.6%. Proteins expressed using a pET-14b vector carry a N-terminal His-tag
coding sequence, that aids in purification o f the recombinant protein using affinity
chromatography, followed by a thrombin cleavage site and three cloning sites. Unique
sites are shown on the vector map. The sequence is numbered by the pBR322 convention,
so the T7 expression region is reversed on the circular map. The cloning/expression
region o f the coding strand transcribed by T7 RNA polymerase is also shown in the map.
SH2 gene and plasmid vector (pET-14b) were enzymatically digested using Nde I and
Xho I enzymes at 37 °C for 4 h. The vector and insert were ligated in ratio 1:10
(Velicharla, 2004) and used for transformation using BL21 DE3 (pLysS) cells.

27
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Figure 2.1. pET-14b Vector Map.

2.1.1.1.2 Bacterial strain
The bacterial strain used to transform the SH2 gene was BL21 (DE3) pLysS
Competent Cells (Stratagene, USA), which are chemically competent E.coli cells used for
tight control o f protein expression in T7 RNA Polymerase-based systems. The cells are
resistant to the lytic bacteriophages T1 and T5. The BL21 (DE3) pLysS strain is a
derivative o f E.coli B. It is deficient in both Ion and ompT proteases, resulting in superior
isolation o f intact recombinant proteins. The host is a lysogen o f XDE3, and therefore
carries a chromosomal copy o f the T7 RNA polymerase gene that is controlled by the
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lacUV5 promoter. BL21 (DE3) pLysS uses the T7 RNA promoter to control protein
expression. The strain carries a low-level expression plasmid that expresses the T7
lysozyme gene at nominal levels. T7 lysozyme binds to T7 RNA polymerase, thus
inhibiting transcription by this enzyme. Upon IPTG induction, overproduction o f the T7
RNA polymerase effectively shuts down any low level inhibition by T7 lysozyme. BL21
(DE3) pLysS strain is resistant to chloramphenicol.
2.1.1.1.3. Media
LB agar and LB broth EZMix were purchased from Sigma Aldrich (USA). The
culture medium was prepared as recommended by Sigma and the agar plates were
prepared in the presence o f ampicillin and chloramphenicol.
2.1.1.2. Method
The SH2 gene ligated to pET-14b was transformed into BL21 (DE3) pLysS strain
o f E. coli using the heat shock method. 50 /xL o f these cells were put in an Eppendorf
tube and incubated on ice for 10 min to thaw. The DNA for SH2 gene was added to these
tubes and placed in a water bath at 42 °C for 45 s. The tubes were placed back on ice for
2 min to avoid damage to the cells. 1 mL o f LB broth was added to these tubes and
incubated at 37 °C for 1 h. 200 /xL o f this culture was plated using a sterile plater on three
different prewarmed agar plates. These agar plates had ampicillin (50 /xg/mL) and
chloramphenicol (34 /xg/mL) as antibiotic resistance. The plates were incubated at 37 °C
overnight.
The following day, a few colonies were picked from each plate and added to a
falcon tube containing 4.9 mL o f fresh LB broth in the presence o f ampicillin (50 /xg/mL)
and chloramphenicol (34 /xg/mL). These tubes were incubated at 37 °C at 240 rpm
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overnight. The following day, the tubes that had turned cloudy were stored in 50 % sterile
glycerol for testing for protein overexpression.
2.1.2. Protein Expression
2.1.2.1. Materials
2.1.2.1.1. Isopropyl-fl-D-Thiogalactopvranoside (IPTG)
IPTG (FW 238.3 g/mol), purchased from Sigma Aldrich (USA), is an artificial
inducer o f the lac operon. It induces the activity o f beta-galactosidase by strongly binding
and inhibiting the lac repressor (Sambrook and Russel, 2001). A synthetic analog o f
galactose, IPTG cannot be hydrolyzed and broken down by the cell. Hence, its
concentration remains constant during an experiment.
2.I.2.2. Method
A 100 mL overnight bacterial culture was prepared with the glycerol stock o f the
colony picked from the agar plate in the presence o f ampicillin (50 /tg/mL) and
chloramphenicol (34 /xg/mL). Following day, a fresh 500 mL culture was inoculated with
the overnight culture in the presence o f antibiotics at the same concentration. The culture
was grown till ODeoo = 0.5; the log phase o f growth for E. coli', at which point the protein
overexpression was induced with 0.4 mM IPTG. This concentration was empirically
determined. 2 mL aliquots were taken from the culture before induction; and every hour
post induction for 4 hours. These aliquots were centrifuged at 14,000 rpm, the
supernatant was discarded and the cell pellets were stored at -80 °C for analyzing the
protein expression level using SDS-PAGE. At the end o f 4 h the cells were harvested by
centrifuging them at 6500 rpm for 10 min. These cells were stored at -80 °C till further
use for purification.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

31

2.1.3. Sodium Dodecyl Sulfate-Polyacrylamide
Gel Electrophoresis (SDS-PAGE)
2.1.3.1. Materials
2.1.3.1.1. Sodium Dodecyl Sulfate
SDS (FW 288.38 g/mol) was ordered from Sigma Aldrich (USA). SDS (CH 3(CH 2)io-CH2OS 0 3 'Na+) is an anionic detergent that binds strongly to a protein in a
specific mass ratio o f 1.4:1 and in doing so denatures the protein. Thus, SDS confers a
negative charge to the polypeptide in proportion to its length; i.e., the denatured
polypeptides become "rods" o f negative charge cloud with equal charge or charge
densities per unit length.
2.1.3.1.2. Dithiothreitol (D T P
DTT (FW 154.25 g/mol, C4 H 10O 2S2), purchased from Sigma Aldrich (USA),
reduces any disulfide bonds present holding together the protein tertiary structure.
2.1.3.1.3. Ammonium Persulfate (APS)
APS (FW 228.20 g/mol, (NH 4 )2 S2 0 8 ) was ordered from Sigma. Polymerization o f
acrylamide and bisacrylamide monomers is induced by ammonium persulfate (APS),
which spontaneously decomposes to form free radicals. A 10% w/v fresh solution was
prepared by dissolving APS in dl water.
2.1.3.1.4. N,N,N',N’-Tetramethvlethylenediamine (TEMED)
TEMED (FW 116.21 g/mol, C 6H 16N 2) was purchased from Sigma Aldrich (USA).
It is a free radical stabilizer, which is generally included to promote polymerization.
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2.1.3.1.5. Protein molecular weight marker
The molecular weight o f the proteins can be determined by comparing against a
number o f standard proteins, known as molecular mass marker. This marker was ordered
from Fermentas.
2.1.3.1.6. Loading buffer
The protein sample to be analyzed on SDS-PAGE is mixed with 3X SDS-PAGE
sample buffer (250 mM Tris-Cl, pH

6 .8 ,

5% SDS, 0.25% bromophenol blue, 25%

glycerol) and DTT (1/20 v/v) is added freshly. The ionisable tracking dye, bromophenol
blue, allows the electrophoretic run to be monitored, and glycerol gives the sample
solution density thus allowing it to settle down to the bottom o f the loading well.
2.1.3.1.7. Staining and destaining solutions
The gel was stained with Coomassie blue, ordered from Sigma. The gels were
stained in staining solution (45% methanol, 45% dl water, 10% acetic acid, and 0.1% w/v
Coomassie blue dye) overnight before washing them in a destaining solution (45%
methanol, 45% dl water, and 10% acetic acid).
2.I.3.2. Method
The 2 mL aliquots stored after overexpression were thawed. 50 //.L o f 3X sample
loading buffer was added to the cells in the presence o f DTT. These samples were boiled
at 100 °C for 5 min along with the protein molecular weight marker. The samples were
allowed to cool to room temperature before loading them onto the SDS-PAGE. The gel
electrophoresis tank was filled with 200 mL o f running buffer. The gels were run at a
constant voltage o f 200 V and current o f 50 mA till the tracking dye reached the end o f
the gel. The gel was removed and put in a staining solution on a rocker to stain overnight.
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The gel was next washed in a destaining solution, which removed the unbound
background dye from the gel leaving stained proteins visible as blue bands on a clear
background. The molecular weight o f the proteins was determined by comparing against
a number o f standard proteins, known as molecular mass marker.
2.1.4. Immunoblot Analysis
2.1.4.1. Materials
2.1.4.1.1. Nitrocellulose membrane
Nitrocellulose membrane is a high-quality membrane ideal for blotting o f proteins
and nucleic acids. This membrane was ordered from Invitrogen (Catalog no. LC2000).
This membrane with pore size o f 0.2 fim is especially suitable for proteins with molecular
weight less than 20 kDa.
2.1.4.1.2. Anti’His HRP conjugates
Anti-His HRP Conjugates were ordered from Qiagen (USA) and consist o f mouse
monoclonal IgG l Anti-His Antibodies coupled to HorseRadish Peroxidase (HRP). They
can be used for direct detection o f any protein with an accessible

6 xHis

tag by

chromogenic or chemiluminescent methods. They eliminate the need for secondary
antibodies, thereby saving time and expense in blotting and ELISA procedures. The
conjugates are available in highly specific Penta-His, TetraH is, and RGS-His forms.
Anti-His HRP conjugates are supplied with a specially formulated Blocking Reagent and
Blocking Reagent Buffer to ensure optimal specificity and sensitivity.
2.1.4.1.3. 6xHis protein ladder
The 6 xHis Protein Ladder serves as a molecular weight standard, and as a positive
control for dot blotting. The 6 xHis Protein Ladder consists o f five 6 xHis-tagged proteins
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ranging from 15 to 100 kDa. Each o f the proteins that make up the 6 xHis Protein Ladder
is tagged at the N-terminus with the (His )6 sequence; therefore, they can be detected by
any o f the QlAexpress detection reagents including the Anti-His HRP conjugate.
2.1.4.1.4. 4-chloro-l -naphthol
4-chloro-l-naphthol (FW 178.61 g/mol, C 10H 7CIO) was ordered from Qiagen. It
is a substrate, which upon reacting with HRP produces a blue colored insoluble
precipitate.
2.1.4.2 Method
The 2 mL aliquot collected 4 h post induction with IPTG was centrifuged at
14,000 rpm and the supernatant was discarded. The resulting cell pellet was diluted by
adding varying amounts o f dilution buffer for denaturing conditions

(8

M urea, 0.1 M

NaH 2P 0 4 , 0.01 M Tris, pH 8.0), ranging from 20 fiL to 200 fiL. 2 pL o f each o f these
dilutions were blotted onto the nitrocellulose membrane. The membrane was allowed to
dry for 30 min. The membrane was washed twice with TBS buffer and incubated for 1 h
in Anti-His HRP conjugate blocking buffer supplied by the manufacturer. It was washed
with TBS-Tween/Triton buffer followed by TBS buffer. The membrane was then
incubated in the Anti-His HRP conjugate solution (1:1000 dilution o f Anti-His HRP
conjugate in blocking buffer) overnight. Next day it was washed with TBS-Tween/Triton
buffer. The membrane was stained with HRP staining solution. This solution was
prepared by dissolving 18 mg 4-chloro-l-naphthol in

6 mL

methanol. 24 mL lx Tris

saline (1 OX Tris saline: 9% w/v NaCl in 1M Tris-Cl, pH 8.0) was added to the methanol
followed by 60 pL hydrogen peroxide. This staining solution is stable only for a short
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period. The membrane was incubated in this staining solution until a signal was clearly
visible.
A similar procedure was followed for a negative control which comprised o f the
culture aliquot collected before induction with IPTG. The manufacturer supplied 6 xHis
protein ladder was used as a positive control.
2.1.5. Cell Lysis
2.1.5.1. Materials
2.1.5.1.1. Sonicator
The cells were lysed using Sonicator® 3000 from Misonix Inc. and was provided
with a microtip used to generate high frequency sound waves which shear the cell walls.
2.1.5.1.2. Protease inhibitor cocktail
A

protease

inhibitor

cocktail

consisting

of

AEBSF

(4-(2-aminoethyl)

benzenesulfonyl fluoride), phosphoramidon, pepstatin A, bestatin, and E-64 was added to
these suspensions at a ratio o f 1 mL per 20 g wet cell paste to limit proteolysis during
purification.
2.1.5.2. Method
The cells harvested after overexpression were freeze thawed and 3 mL o f
resuspension buffer (20 mM Tris-HCl, pH 8.0) was added per 100 mL o f cell culture.
This suspension comprised o f the soluble proteins was sonicated on ice for 30 s with 30 s
interval in between four times. The resulting lysate was centrifuged at 10,000 rpm at 4 °C
for 30 min. The supernatant was discarded and 3 mL o f isolation buffer (2 M urea, 20
mM Tris-HCl, 0.5 M NaCl, and 2% Triton X-100, pH 8.0) per 100 mL cell pellets was
added to the inclusion bodies. The suspension was sonicated and centrifuged. This was
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repeated twice to isolate the inclusion bodies. These inclusion bodies were stored at -80
°C in the presence o f 50 /xL protease inhibitor for further use in purification.
2.1.6. Protein Purification
2.1.6.1. M aterials
2.1.6.1.1, AKTA prime
AKTA FPLC, shown in Figure 2.2, is a fully automated liquid chromatography
system designed for research scale purification o f proteins. The system simplifies the
transition from laboratory to full scale production.
AKTA FPLC features:
• Flow rates up to 20 mL/min and pressures up to 5 MPa.
• One working platform for all liquid chromatography techniques suitable for protein
purification, from micro-gram to gram scale.
• Method templates as a basis for creating customized methods.
• Continuous monitoring o f A 28o-

Figure 2.2. AKTA FPLC System
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2.I.6.I.2. HisTrap™ HP columns
Histidine tagging is the most used form o f tagging recombinant proteins. HisTrap
HP columns, shown in Figure 2.3, are prepacked with Ni Sepharose High Performance
can also be used for the purification o f tagged proteins containing shorter or longer
polyhistidine tags, such as (histidine^ or (histidine)io. The shorter (histidine^ will bind
weakly and the longer (histidine)io will bind strongly compared with (histidine)6. This
difference in binding strength can be used during purification, since (histidine) 10 binds
strongly, a higher concentration o f imidazole can also be added to the lysed cells and
used during the binding and washing steps before elution. This can facilitate the removal
o f contaminants which may otherwise get co-purified with the tagged target protein.

Figure 2.3. 1 mL and 5 mL HisTrapTM Columns.
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2.I.6.2. Method
2.I.6.2.I. Purification of the SH2 protein
expressed as inclusion bodies
The inclusion bodies isolated after cell lysis were thawed. They were dissolved in
4 mL solubilization buffer (6 M GdnHCl, 20 mM Tris-HCl, 0.5 M NaCl, 10 mM
imidazole, and 1 mM 2-mercaptoethanol, pH 8.0) on a rocker for 1 h. This sample was
filtered through 0.45 /mi filter using a syringe. The column was equilibrated with 50
column volumes o f solubilization buffer. The A28o was monitored, and upon reaching a
steady baseline the column equilibration was stopped. At this time, the sample was
loaded onto the column and washed with the solubilization buffer. The increase in A28o
indicated the unbound host cell proteins being washed off the column. The column was
washed until a steady baseline was attained. The protein bound onto the column was
washed with 50 column volumes o f refolding buffer (6 M urea, 20 mM Tris-HCl, 0.5 M
NaCl, 5 mM imidazole, and 1 mM 2-mercaptoethanol, pH 8.0). On-column refolding o f
the protein was attempted by running a linear gradient o f 6 M-0 M urea. This refolding
was achieved by running 50 column volumes o f a linear gradient o f refolding buffer and
wash buffer (20 mM Tris-HCl, 0.5 M NaCl, 10 mM imidazole, andl mM 2mercaptoethanol, pH 8.0). The final elution step was performed by running a linear
gradient o f 0.01 M-0.5 M imidazole. The target protein was eluted by running 100
column volumes o f a gradient o f wash buffer and elution buffer (20 mM Tris-HCl, 0.5 M
NaCl, 0.5 M imidazole, and 1 mM 2-mercaptoethanol, pH 8.0). The A2so was monitored
and fractions were collected upon observing absorbance peaks. These fractions were
stored at 4 °C after adding 0.1% w/v sodium azide to avoid bacterial growth and later
analyzed using SDS-PAGE.
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2.I.6.2.2. Purification of the SH2 protein
expressed in soluble fraction
The supernatant was collected and stored after lysing and centrifuging the cells in
resuspension buffer. This supernatant was filtered through a Whatman fdter paper and a
second fdtration step was done using a 0.45 fim filter. 20 mM imidazole and 1 mM 2mercaptoethanol was added to this soluble fraction to minimize the binding o f host cell
proteins to the column. The column was equilibrated by running 50 column volumes o f
binding buffer (20 mM Tris-HCl, 0.5 M NaCl, 20 mM imidazole, and 1 mM 2mercaptoethanol, pH 8.0). Upon reaching a steady baseline, the sample was applied onto
the column and washed with the binding buffer. The column was washed with 50 column
volumes o f wash buffer. The elution was done by running a linear gradient o f 0 M-0.5 M
imidazole. The fractions were collected by observing A 280 and stored as described earlier.
2.1.7. Dialysis
2.1.7.1. Materials
2.1.7.1.1. Dialysis tubing
The dialysis tubing (Spectrum®) with a molecular weight cut-off (MWCO) o f
10000 daltons was chosen to dialyze the 16734 dalton SH2 domain. The dry tubing was
pre-treated by soaking and rinsing in ddl water at 70 °C thrice before use.
2.1.7.2. Method
The purified protein fraction was dialyzed against a buffer (20 mM sodium
phosphate, 10 mM NaCl, and 1 mM DTT, pH 7.8) to get rid o f the imidazole and other
salts used in the purification process. The ratio o f protein to buffer was 1:300. The
dialysis was done with three buffer changes. The first two buffer changes were at the end
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o f four hours, and finally the protein was dialyzed overnight. Upon completion, the buffer
and protein were both stored at 4 °C.
2.1.8. Limited Proteolysis
2.1.8.1. Materials
2.1.8.1.1. Restriction erade thrombin
Restriction-grade thrombin (Catalog no. 69671-3) was purchased from Novagen.
Thrombin specifically cleaves the amino acid sequence Leu-Val-Pro-Arg IGly-Ser in His
tagged proteins, thereby separating the His tag from the recombinant protein. The kit also
supplied a 48 kDa cleavage-control protein to be used as a positive control which upon
cleavage with thrombin yielded 35 kDa and 13 kDa protein fragments.
2.I.8.2. Method
The thrombin was diluted in a 1:25 ratio using a thrombin dilution buffer (50 mM
sodium citrate, pH 6.5, 200 mM NaCl, 0.1% PEG-8000, and 50% glycerol). The reaction
mixture comprised o f 5 /rL 10X Thrombin Cleavage Buffer (200 mM Tris-HCl pH 8.4,
1.5 M NaCl, and 25 mM CaCl2), 2 fiL diluted thrombin, 20 fxL purified protein and the
volume was brought up to 50 iiL by adding dl water. A positive control supplied by
Novagen was used to test the activity o f the thrombin. This control was a 48 kDa protein;
which upon incubation with thrombin was cleaved into a 35 kDa and a 13 kDa fragments.
The positive control was carried out in a similar manner by using the cleavage control
protein. The negative control comprised o f all the reagents except the diluted thrombin.
The temperature at which the reaction was carried out was determined empirically. The
reaction mixture was incubated at 4 °C for 16 h. Aliquots were collected at 2h, 4h, 8h,
and 16h intervals to monitor the time required for cleavage. These aliquots were treated
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with 3X sample loading buffer and heated at 100 °C for 3 min to completely denature the
thrombin and inhibit any further reaction.

2.2. Biophysical Techniques
2.2.1. Ultraviolet/Visible Spectroscopy
Ultraviolet/visible spectroscopy involves the absorption o f ultraviolet/visible light
by a molecule causing the promotion o f an electron from a ground electronic state to an
excited electronic state. A schematic block diagram o f a UV spectrometer is shown in
Figure 2.4.
Lamp

Monochromator

Reference

Detector

Ratio

Oatpnt

*.!*-,j.1 T \

mm

Detector

Figure 2.4. Schematic diagram o f UV Spectrometer.

This instrument works on the Beer-Lambert’s law, A = ebc, where A is
absorbance, e is the extinction coefficient with units o f L/mol-cm, b is the path length o f
the sample (cm), which is the path length o f the cuvette in which the sample is contained,
and c is the concentration o f the protein in solution, expressed in mol/L.
UV spectroscopy determined the concentration o f the purified protein that was
used for further characterization using CD spectroscopy and DSC. The absorbance was
noted at a wavelength o f 280 nm to calculate the protein concentration (Gill and von
Hippel, 1989).
2.2.2. Capillary Electrophoresis (CE)
As the name suggests, CE involves electrophoresis o f simple molecules, organic
and inorganic ions, peptides, proteins, carbohydrates and nucleic acids in a narrow bore
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capillary (typically 50 jam internal diameter). CE was used to demonstrate the purity o f
the recombinant protein as well as to monitor the proteolytic cleavage o f the (His)6 tag
using thrombin over a period o f 16 hours. This approach was used keeping in mind the
pharmaceutical application o f CE, which is to demonstrate the purity o f antibiotic, or the
presence or amount o f impurities. The basic instrumentation consists o f four parts as
shown below. A narrow diameter capillary is required for the separation, a high voltage
power supply is required to drive the separation, a detector is required to detect the
presence and amount o f analyte and a safety interlock-equipped enclosure is used to
protect the operator from high voltage (not shown). A schematic block diagram o f CE is
shown in Figure 2.5.

High-voltag«
supply
D etector
Capillary

Buffer
Figure 2.5. Schematic Diagram o f Capillary Electrophoresis.

Either pressure or vacuum is applied to the sample and 10 - 100 nL is injected, or
an electrical current is applied through the sample and only the charged molecules enter
the capillary. The resulting migration o f a charged particle in CE is a sum o f the
electrophoretic flow, which is determined by the size and charge on the molecule, and the
electroosmotic flow, which is determined by the charge on the inner surface o f the
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capillary. One advantage o f capillaries is that they reduce problems resulting from
heating effects. Because o f the small diameter o f the capillary there is a large surface-tovolume ratio, which gives enhanced heat dissipation. This heat dissipation helps to
eliminate both convection currents and zone broadening owing to increased diffusion
caused by heating. It is therefore not necessary to include a stabilizing medium in the
capillary and allows free-flow electrophoresis.
The capillary length plays no role in separation efficiency but has an important
role in migration time and high separation efficiencies are best achieved through the use
o f high voltages. There is a practical limit to the amount o f voltage that can be applied, as
determined by the capillary length. Voltages in the range o f 10 to 50kV with capillaries
o f 50 to 100 cm are commonly used.
A high voltage is applied across the capillary and component molecules in the
injected sample migrate at different rates along the length o f the capillary tube.
Electrophoretic migration causes the movement o f charged molecules in solution towards
an electrode o f opposite charge. Owing to this electrophoretic migration, positive and
negative sample molecules migrate at different velocities. The higher the positive charge
on a molecule, the faster it travels towards the cathode, with highly negative charged
molecules being the slowest to migrate. As the separated molecules approach the cathode,
they pass through a detector window where they are detected by an ultraviolet monitor
that transmits signal to a recorder, integrator (mass spectroscopy in some cases) or
computer. The signal plotted as absorbance against time is called an electropherograph.
A neutral capillary was rinsed with citrate-MES buffer, pH 6.0 for 10 minutes.
lOkV voltage was applied for 10 minutes across the capillary to rinse out all the
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contaminants. Pressure was applied at 5 psi for 3 seconds to inject 2nL o f the tensin-SH2
protein into the capillary. Separation was achieved by applying a voltage o f lOkV for lh.
The source filter was set to 214 nm.
2.2.3. Circular Dichroism Spectroscopy
CD measures the interaction o f circularly polarized light with molecules.
Circularly polarized light comes in left- and right-handed forms, like screw threads.
These forms interact equally with non-chiral chromophores, but differently when the
chromophore has a right- or left-handed form. The result is a small difference in the
extinction coefficients for left- and right-polarized light, which varies with wavelength.
In proteins, the chiral arrangement o f peptide bonds in secondary structures such
as a-helix and /3-sheet leads to characteristic CD spectra at UV wavelengths. Alteration o f
the relative orientations, because o f conformational or structural variations, causes
changes in the CD spectrum.
2.2.3.I. Determination of protein secondary
structure by circular dichroism
Secondary structure can be determined by CD spectroscopy in the far-UV spectral
region (190-250 nm). At these wavelengths the chromophore is the peptide bond, and the
signal arises when it is located in a regular, folded environment. Alpha-helix, beta-sheet,
and random coil structures each give rise to a characteristic shape and magnitude o f CD
spectrum. The approximate fraction o f each secondary structure type present in any
protein can thus be determined by analyzing its far-UV CD spectrum as a sum o f
fractional multiples o f such reference spectra for each structural type.
Like all spectroscopic techniques, the CD signal reflects an average o f the entire
molecular population. Thus, while CD can determine that a protein contains about 50%
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alpha-helix, it cannot determine which specific residues are involved in the alpha-helical
portion. Far-UV CD spectra require 200 pi o f solution containing 50 pg/ml to 1 mg/ml
protein, in any buffer which does not have a high absorbance in this region o f the
spectrum. (High concentrations o f DTT, histidine, imidazole, or chloride ions for
example, cannot be used in the far-UV region).
2.2.3.2. Information about protein tertiary
structure from circular dichroism
The CD spectrum o f a protein in the near-UV spectral region (250-350 nm) can be
sensitive to certain aspects o f tertiary structure. At these wavelengths the chromophores
are the aromatic amino acids and disulfide bonds, and the CD signals they produce are
sensitive to the overall tertiary structure o f the protein. Signals in the region from 250270 nm are attributable to phenylalanine residues, signals from 270-290 nm are
attributable to tyrosine, and those from 280-300 nm are attributable to tryptophan.
Disulfide bonds give rise to broad weak signals throughout the near-UV spectrum. If a
protein retains secondary structure but no defined three-dimensional structure (e.g. an
incorrectly folded or "molten-globule" structure), the signals in the near-UV region will
be nearly zero. On the other hand, the presence o f significant near-UV signals is a good
indication that the protein is folded into a well-defined structure. The near-UV CD
spectrum can be sensitive to small changes in tertiary structure because o f protein-protein
interactions and/or changes in solvent conditions. The signal strength in the near-UV CD
region is much weaker than that in the far-UV CD region. Near-UV CD spectra require
about 1 ml o f protein solution with concentration ranging from 0.25 mg/ml to 2 mg/ml.
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2.2.3.3. Spectral interpretation
and deconvolution
2.2.3.3.I. Interpretation of the spectra
The relationship between the secondary structure o f the protein and the CD
spectrum has been realized quite early and was published in 1969 by Greenfield and
Fasman. The data obtained after performing far-UV CD experiments can be compared
with the standard spectra o f poly-L-lysine, shown in Figure 2.6, to study the structure o f
the polypeptides.

alpha helK

beta sheet
random coil

190

210

230

250

wavelength {nm}

Figure 2.6. Actual Fit o f a Sample Data Against the Fasman Poly-lys Standards
(Greenfield and Fasman, 1969).
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2.2.3.3.2. Deconvolution
The CDPro software suite, which includes programs CDSSTR, CONTIN, and
SELCON3 (Sreerama and Woody, 2000) was used to deconvolute the far-UV CD spectra
into contributions from the a helix, /3 sheet, /3 turn, and coil. The software programs were
used as recommended over the wavelength range o f 195-240 nm, which included the
significant part o f the data from the CD spectrum o f the tensin-SH2 protein. The chosen
reference set, consisting o f the far-UV CD spectra o f 43 proteins o f known secondary
structure content, was the best option among all reference sets available in the software
suite, and was also the recommended option in the software for the input data in various
experiments.
All CD studies o f recombinant tensin-SH2 domain contained the His-tag. The
experiments were done at 22-24 °C with a Jasco J-810 CD spectropolarimeter (Japan).
The step size was 0.1 nm; scanning speed, 0.3 nm s'1; response time, 0.3 s; number o f
scans, 60 (far-UV) or 150 (near-UV). Far-UV measurements were taken in the range
190-260 nm at 25 °C in a 0.1 cm path length cuvette. The protein concentration was 0.12
mg mL-1 in 25 mM sodium phosphate, 10 mM NaCl, lm M /3-mercaptoethanol, pH 7.8.
Near UV spectra were taken in the range 250-360 nm in a 1 cm path length cuvette. The
protein concentration was 1 mg mL-1 in the same buffer as above. Buffer baselines were
collected with the same instrument settings and subtracted from the respective sample
spectra. Quartz cuvettes filled with the protein sample were placed in the sample
chamber, purged o f air with nitrogen. This purging was done to avoid the far-UV light
absorption by molecular oxygen, which masks the CD signal.
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2.2.4. Differential Scanning Calorimetry (DSC)
DSC is used to investigate protein stability and is combined with other
biophysical methods to link thermodynamics, structure, and function.
A protein in aqueous solution is in equilibrium between the native (folded)
conformation and its denatured (unfolded) conformation. The stability o f the native state
is based on the magnitude o f the Gibbs free energy (AG) o f the system and the
thermodynamic relationships between enthalpy (AH) and entropy (AS) changes. A
positive AG indicates the native state is more stable than the denatured state - the more
positive the AG, the greater the stability. For a protein to unfold, stabilizing forces need
to be broken. Conformational entropy overcomes stabilizing forces allowing the protein
to unfold at temperatures where entropy becomes dominant. DSC measures AH o f protein
unfolding because o f heat denaturation. The higher the transition midpoint (Tm), the
more stable the protein at lower temperatures. During the same experiment DSC also
measures the change in heat capacity (ACp) for protein denaturation. Heat capacity
changes associated with protein unfolding are primarily because o f changes in hydration
o f side chains that were buried in the native state but become solvent exposed in the
denatured state. M any factors are responsible for the folding and stability o f native
proteins, including hydrophobic interactions, hydrogen bonding, conformational entropy,
and the physical environment.
The data from a typical DSC experiment is called a thermogram. Protein
unfolding is recognized as a sharp endothermic peak centered at a characteristic
temperature called the transition midpoint (Tm). Tm, AH and ACp o f the transition are
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calculated by fitting the data to a two-state transition model using non-linear least squares
regression analysis.
2.2.5. Mass Spectrometry (MS)
Two advances in the MS o f peptides and proteins were announced independently
towards the end o f 1980s and, with ongoing developments, are still at the center o f
current methodologies. Both developments were the refinement and application o f
ionization techniques, namely Electrospray Ionization (ESI) and Matrix-assisted Laser
Desorption and Ionization (MALDI), and both increased the sensitivity and upper mass
limit o f peptides or proteins amenable to mass spectrometry. Such was the impact o f
these techniques that the originators were awarded Nobel Prize in 2002.
Although the process o f ionization is not fully understood, ESI is simple in
practice in that the method only requires a solution o f the analyte to be sprayed across an
electric field. The resulting analyte ions are sampled into a mass analyzer and the sample
usually observed as protonated molecules in the positive ion detection mode. Although
initially used to measure intact proteins, ESI was also found to detect lower molecular
mass peptides with newfound sensitivity. One advantage o f the technique is that as the
molecular mass o f the peptide increases, so do the dimensions o f the molecule and the
number o f basic sites within the molecule; hence, higher mass samples can collect more
protons per molecule. Thus, a peptide o f molecular mass 500 daltons maybe only slightly
protonated, whereas a protein o f mass 20 kDa may average 20 protons per molecule and
the sample ions would appear at mass-to-charge 500 and 1000, respectively, in an
electrospray mass spectrum.
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Atoms can be deflected by magnetic fields - provided the atom is first turned into
an ion. Electrically charged particles are affected by a magnetic field although electrically
neutral ones are not affected. The sequence o f events is as follows:
Stage 1: Ionization
The atom is ionized by knocking one or more electrons off to give a positive ion.
This is true even for chemical species which one would normally expect to form negative
ions (e.g. chlorine) or never form ions at all (e.g. argon). Mass spectrometers always
work with positive ions.
Stage 2: Acceleration
The ions are accelerated so that they all have the same kinetic energy.
Stage 3: Deflection
The ions are deflected by a magnetic field according to their masses. The lighter
they are, the more deflected they are. The amount o f deflection also depends on the
number o f positive charges on the ion - in other words, on how many electrons were
knocked o ff in the first stage. The more the ion is charged, the more it gets deflected.
Stage 4: Detection
The beam o f ions passing through the machine is detected electrically. A
schematic o f mass spectrometer is shown in Figure 2.7.
The protein was dialyzed in carbonate buffer (25mM sodium carbonate, lOmM
NaCl, and pH 9.6) before sending the sample for mass spectrometry at UIUC. This buffer
was used to avoid the ionization o f phosphate ions when subjected to electron spray
ionization.
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Figure 2.7. Schematic Diagram o f Mass Spectrophotometer.
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CHAPTER 3
RESULTS
3.1. Tensin-SH2 Domain Overexpression
The SH2 gene ligated to pET-14b was transformed into BL21 (DE3) pLysS strain
o f E. coli using the heat shock method. 50 pi o f BL21 (DE3) cells were put in an
Eppendorf tube and incubated on ice for 10 minutes to thaw. The DNA encoding SH2
gene was added to these tubes and placed in a water bath at 42 °C for 45 s. These tubes
were placed back on ice for 2 min to avoid damage to the cells. 1 ml o f LB was added to
these tubes and incubated at 37 °C for 1 h. 200 pi o f this culture was plated using a sterile
plater on three different prewarmed agar plates. These agar plates had ampicillin (50
pg/ml) and chloramphenicol (34 pg/ml) as antibiotic resistance. The plates were
incubated at 37 °C overnight. The following day, a few colonies were picked from each
plate and added to a falcon tube containing 4.9 ml o f fresh LB broth in the presence o f
ampicillin (50 pg/ml) and chloramphenicol (34 pg/ml). These tubes were incubated at 37
°C at 240 rpm overnight. The following day, the tubes that had turned cloudy were stored
in 50 % sterile glycerol to test for protein overexpression.
A 100 ml overnight bacterial culture was prepared with the glycerol stock o f the
colony picked from the agar plate in the presence o f ampicillin (50 pg/ml) and
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chloramphenicol (34 pg/ml). The following day, a fresh 500 ml culture was inoculated
with the overnight culture in the presence o f antibiotics at the same concentration. The
culture was grown till OD60o = 0.5; the log phase o f growth for E. coli; at which point the
protein overexpression was induced with 0.4 mM IPTG. This concentration was
empirically determined. 2 ml aliquots were taken from the culture before induction; and
every hour post induction for 3 h. At the end o f 3 h the cells were harvested by
centrifuging at 6500 rpm for 10 min. These cells were stored at -80 °C till further use for
purification. The selected aliquots were analyzed on a 12% SDS-PAGE to analyze the
overexpression as shown in Figure 3.1

kDa

Figure 3.1.12% SDS-PAGE Showing the Overexpression o f SH2 Domain in E. coli.
Lane M: Protein Marker; Lane 1: Aliquot 2 h Post Induction; Lane 2: 3 h Post Induction;
Lane 3: 4 h Post Induction; and Lane 4: Aliquot Pre-induction with IPTG.
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3.2. Im m unoblot Analysis
Chromogenic detection was used to view the presence o f His-tagged target
protein. This method employs the use o f a substrate 4-chloro-l-naphthol which upon
reacting with HRP produces a blue colored insoluble precipitate. A small test was done
to confirm this color change wherein solutions o f HRP at varying concentrations were
reacted with 4-chloro-l-naphthol and the reaction was observed (Figure 3.2A). In this
experiment, 6x-His tagged ladder was used as a positive control. This ladder is a mixture
o f five different His-tagged proteins. An uninduced sample was collected and used as a
negative control (Figure 3.2B). The dot blot and detection protocol for SH2 domain was
followed from the Qiagen manual. Different dilutions o f the overexpressed protein after
3h were made and blotted onto the nitrocellulose membrane (Figure 3.2C). The controls
were not used on this membrane as they had been used before and because o f the lack o f
space on the membrane.

Figure 3.2. Immunodetection. (A) The reaction Between Varying Concentrations o f HRP
with 4-chloro-l-naphthol (B) The result o f the Positive and Negative Controls in the Dot
Blotting Technique (C) The Detection o f Different Dilutions o f the SH2 Protein on a
Nitrocellulose Membrane.
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3.3. Protein Purification
3.3.1. Protein Purification Protocol
for Inclusion Bodies
Resuspension buffer was added to cells harvested 3 h post induction with IPTG.
They were sonicated for 30s X 3; with 30 s interval between each pulse. The cells were
centrifuged at 10000 rpm for 20 min and the resuspended pellet was sonicated in isolation
buffer as before. The resuspended pellet was again centrifuged at 10000 rpm and this was
repeated twice. The resulting inclusion bodies were solubilized in solubilization buffer
and loaded onto the HisTrap column. The bound protein was washed on-column using
refolding buffer. On-column refolding o f the protein was done by running a linear 6-OM
gradient o f urea. The unbound proteins were washed off using wash buffer and eluted
using a linear gradient o f 0 M-0.5 M imidazole. Fractions o f eluted protein were collected
by monitoring the absorbance at 280 nm; an inbuilt feature in the AKTAprime. These
fractions were analyzed on a SDS-PAGE for yield as well as purity as shown in Figure
3.3.
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Figure 3.3. SDS-PAGE Showing Analysis o f Purified Fractions. Lane M: Protein
Molecular Weight Marker; Lane 1: Purified SH2 Domain; Lane 2: Purified SH2 Domain
with Contaminants; Lane 3: Overexpressed SH2 Domain

3.3.2. Determining the Solubility of
Overexpressed Protein
Bacterial cells collected 3 h post induction were lysed by sonication on ice for 40
s, and the resulting suspensions were centrifuged at 10,000 rpm for 15 min at 4 °C.
Thereafter, small amounts o f the resulting cell pellet and supernatant were analyzed by
SDS-PAGE, as shown in Figure 3.4, to check for the amount o f protein in expressed in
the soluble fraction and in the inclusion bodies.
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Figure 3 .4 .12% SDS-PAGE Showing the Protein Expressed in Soluble Fraction and
Inclusion Bodies. Lane 1: Cell Pellet (Inclusion Bodies); Lanes 2, 3 ,4 , and 5:
Supernatant (Soluble Fraction); Lane 6: Spillover from Lane 5.

3.3.3. Protein Purification
of the Soluble Fraction
The cell pellets harvested after 3 h post induction were added to resuspension
buffer and sonicated for 30s X 4; with 30s interval in between. The suspension was
centrifuged at 10000 rpm for 20 minutes. The supernatant was collected and filtered
through a Whatman filter paper followed by a 45 pm filter using a syringe. This soluble
fraction was loaded onto the HisTrap column and washed with 20 column volumes o f
binding buffer. The unbound proteins were washed off until the absorbance at 280 nm
reached zero. Next, the column was washed with 20 column volumes o f wash buffer to
elute the weakly bound proteins off the column. The protein bound onto the column was
eluted using a 0 M-0.5 M linear gradient o f imidazole. The fractions collected at various
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time intervals were analyzed on a SDS-PAGE to determine the purity and yield as shown
in Figure 3.5.
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Figure 3.5. 12% SDS-PAGE Analysis Showing Fractions Collected from Soluble
Fraction Purification. Lane 1: Overexpressed SH2 Protein; Lanes 2, 3, 4, and 5: Purified
SH2 Protein Fractions.

3.4. Initial Protein Characterization
The amino acid sequence o f the tensin-SH2 domain was used to determine initial
characterization parameters like molecular mass, isoelectric point (pi) and extinction co
efficient. The isoelectric point determination was necessary to determine the buffer
compatibility so as to keep the protein soluble. The extinction co-efficient was necessary
to determine the protein concentration. This analysis was carried out using the ExPASy
(Expert Protein Analysis System) server o f the Swiss Institute o f Bioinformatics (SIB).
The calculated molecular mass o f this protein was 16734 daltons (da) and the isoelectric
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point was 9.15 with the His-tag. The extinction coefficient o f the SH2 domain with Histag was 10930 M “'cm '1.

3.5. Lim ited Proteolysis
3.5.1. Analysis by SDS-PAGE
His-tag is about 20 amino acids in length; which implies that the cleaved protein
is about 2 kDa less in molecular weight than the uncleaved fraction. The molecular
weight o f thrombin is 35 kDa. A 1:25 dilution o f the thrombin was made using the
dilution buffer supplied by Novagen. This reaction mixture was incubated at room
temperature on a rocker. Aliquots were collected after 2, 4, 8 and 16 h and the reaction
was stopped by heating the aliquot at 100 °C for 2 min and adding the SDS-PAGE
loading buffer. These aliquots as well as the controls were analyzed on a 12% SDSPAGE as shown in Figure 3.6.
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2h

4h

8h

16h M

Figure 3.6. 12% SDS-PAGE Showing Thrombin Cleavage Analysis.
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3.5.2. Analysis by C apillary Electrophoresis
Tensin-SH2 domain and thrombin were analyzed on the CE individually for
purity and migration time. The SH2 protein sample used to demonstrate the cleavage o f
His-tag using CE was prepared as described in 2.1.8.2.

The protein was in 25 mM

sodium phosphate, 10 mM NaCl, 1 mM /3-mercaptoethanol, and pH 7.8. Aliquots were
collected at 8 and 16 h intervals and boiled at 100 °C for 5 min to inhibit thrombin
activity. SDS-PAGE loading buffer was avoided to inhibit the reaction because o f the
possible damage to the capillary. The resulting electropherograms are shown in Figure
3.7A, Figure 3.7B, Figure 3.7C, and Figure 3.7D.
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Figure 3.7A. Electropherogram Showing Pure SH2 Domain.
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Figure 3.7B. Electropherogram Showing Pure Thrombin.
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Figure 3.7C. Electropherogram Showing Thrombin Cleavage After 8h.
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Figure 3.7D. Elelctropherogram Showing Thrombin Cleavage After 16h.

3.6. Secondary Structure Determination
3.6.1. Secondary Structure Determination
at Optimal pH Value
Figure 3.8 shows SH2 secondary structure in 0 M and 6 M Guanidine HC1. The
protein was in 25 mM sodium phosphate, 10 mM NaCl, 1 mM jS-mercaptoethanol, and
pH 7.8. Data were not collected below 213 nm for 6 M spectra because o f interference by
chloride ions. All spectra are baseline subtracted. The secondary structure content o f the
tensin-SH2 domain, obtained by deconvoluting the far-UV CD spectra using CDPro is
given in Table 3.1.
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Figure 3.8. SH2 Domain in 0 M at pH 7.8 or 6 M GdnHCl.

Table 3.1. Estimates o f Secondary Structure by Deconvolution in 20 mM phosphate
buffer, 10 mM NaCl I mM /3-mercaptoethanol, and pH 7.8.

CONTINLL
SELCON3
CDSSTR
Best
estimate

a helix
0.212
0.243
0.245
0.23+
0.02

SH2 domain at pH 7.8
coil
jS sheet
0.214
0.319
0.214
0.313
0.206
0.317
0.21+
0.32+
0.01
0.01

turn
0.254
0.244
0.229
0.24+
0.01

3.6.2. Secondary Structure Determination
at Extreme pH Values
To observe the secondary structure over an extreme pH range, the protein sample
was dialyzed in a buffer containing 25 mM sodium phosphate, 10 mM NaCl, 1 mM (3mercaptoethanol, and pH 12. The resulting spectrum is shown in Figure 3.9.
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Figure 3.9. Far-UV CD Spectra o f SH2 Domain at pH 12.0.

Similarly, the secondary structure was determined in a buffer containing 25 mM
sodium phosphate, 10 mM NaCl, 1 mM /3-mercaptoethanol, and pH 2.0. as shown in
Figure 3.10.
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Figure 3.10. Far-UV CD Spectra o f SH2 Domain at pH 2.0.

The above sample at pH 2.0 was redialyzed in 25 mM sodium phosphate, 10 mM
NaCl, ImM /3-mercaptoethanol, pH 7.8 to observe the effect o f change in pH over the
secondary structure as shown in Figure 3.11.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

66

20000
10000

-10000
-20000
-30000
-40000
195

205

215

225

235

245

255

w avelength (nm)

Figure 3.11. Far-UV CD Spectra o f SH2 Domain After Readjusting the pH Value from
2.0 to 7.8.

Figure 3.12 shows an overlay o f the secondary structure analysis o f the tensinSH2 domain at different pH values.
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Figure 3.12. Overlay Showing Secondary Structure Determination at Different pH
Values.

3.6.3. Sequence Alignment by
Homology Modeling
Figure 3.13 shows SH2 domain o f human tensin aligned with other homologs.
This amino acid sequence alignment was done using Genedoc (Zhao, 2006).

tensin
1BHF
1D4W
1P13

DTSKYWYKPEISREQAIALLK--DQEPGAFIIRDSHSFRGAYGLAMKVSSPPPTIMQQNK
LE PE PWFFKNL SRKD AERQLLAPGNTHGS FLIRESE STAGS FSLS VRDFDQ - - N Q G E W K
MDAVAVYHGKISRETGEKLLLA- TGLDGSYLLRDSESVPGVYCLCVLY-------- HGYIY
--AEEWYFGKITRRESERLLLNPENPRGTFLVRESETTKGAYCLSVSDFDN--AKGLNVK

tensin
1BHF
1D4W
1P13

KGDMTHELVRHFLIETGPRGVKLKGCPNEPNFGSLSALVYQHSIIPLALPCKLVIPNRD
HYKIRNLDNGGFYIS------------- PRITFPGLHELVRHYTNASDGLCTRLSRPCQT
TYRVSQTETGSWSAETAPGV-------- HKRYFRKIKNLISAFQKPDQGIVIPLQYPVEK
HYKIRKLDSGGFYIT------------- SRTQFSSLQQLVAYYSKHADGLCHRLTNVCP-

Figure 3.13. Human Tensin-SH2 Domain Sequence Alignment with Other SH2 Domains
o f Lck, SLAM, and Src.
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3.7. Tertiary Structure Determination
The near-UV CD spectra o f tensin-SH2 domain was obtained in 25 mM sodium
phosphate, 10 mM NaCl, ImM /3-mercaptoethanol, pH 7.8 as shown in Figure 3.14.
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Figure 3.14. Near-UV CD Spectra o f Tensin-SH2 Domain.

3.8. Biophysical Characterization
3.8.1. Mass Spectrometry
The SH2 sample was dialyzed in 25 mM sodium carbonate, lOmM NaCl, 1 mM
/3-mercaptoethanol, pH 9.6 and sent to University o f Illinois at Urbana-Champaign
(UIUC) Protein services facility for mass spectrometry analysis. The choice o f buffer was
based on the fact that phosphate ions ionize upon undergoing electrospray ionization
(ESI) thereby interfering with the detection process. The exact molecular mass o f the
protein is shown in Figure 3.15.
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Figure 3.15. Mass Spectrometry Result for Tensin-SH2 Domain Showing the Expected
Peak at 16757 Daltons.

3.8.2. Guanidine HC1 (GdnHCl) Induced
Denaturation Monitored by CD
Chemical denaturation o f the SH2 domain was monitored by measuring the
change in ellipticity at 220 nm as a function o f increase in the concentration o f GdnHCl.
Ellipticity at 220 nm as a function o f guanidine concentration is shown in Figure 3.16.
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Figure 3.16. Change in Ellipticity at 220 nm as a Function o f GdnHCl Concentration for
Tensin-SH2 Domain at pH 7.8.

3.8.3. Heat Induced Denaturation
Monitored by DSC
The calorimetric profile o f the tensin SH2 domain is shown in Figure 3.17. The
data were obtained under reducing conditions (1 mM /3-mercaptoethanol); tensin being an
intracellular protein.
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CHAPTER 4
DISCUSSION
SDS-PAGE analysis o f cells harvested 4 h post induction revealed a significant
amount o f target protein being expressed. Immunblot analysis confirmed the presence o f
His-tag in the overexpressed SH2 protein. The initial purification protocol for proteins
expressed in inclusion bodies resulted in little or no target protein. Consequently, the
cells harvested after overexpression were sonicated and the resulting pellets and
supernatant analyzed on a SDS-PAGE. This revealed that a large amount o f the SH2
domain was expressed in soluble fraction. Subsequently, the purification protocol was
modified and the soluble fraction o f the protein was loaded onto the column which
resulted in an improved yield o f 0.2 mg/ml o f the target protein.
SDS-PAGE analysis o f the His-tag removal shows that the His-tag was cleaved
only after 16 h, suggesting that no cleavage took place in 8 h, or it was not sufficient to
be detectable under the used staining conditions. To confirm this finding, a novel
approach o f CE migration time was used. The electropherogram for the SH2 protein
showed a peak o f 0.025 AU 214 after 30 min whereas thrombin showed a peak o f 0.017
AU 214 after 25.5 min. The aliquots collected after 2 and 4 h intervals showed no increase
in the number o f peaks as it should have been in case o f appreciable cleavage being taken
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place. The aliquot analyzed after 8 h showed thrombin with a peak o f 0.022 AU 214 after
25.5 min; and two other peaks o f 0.027 AU 214 at 23.3 min and 0.005 AU 214 at 23.4 min.
The first peak o f 0.027 AU 214 is the uncleaved SH2 domain as the amplitude is
appreciably close to the pure SH2 domain electropherogram. The second closely
following peak o f 0.005 AU 214 is the SH2 domain with the cleaved His-tag. This
argument is supported by the electropherogram after 16 h; where thrombin is seen as
having a peak o f 0.026 AU 214 at 26.1 min as before preceded by two peaks o f 0.026
AU 214 at 23.7 min and 0.0075 AU 214 at 23.8 min. The 50% increase in the amplitude o f
the closely following second peak is attributed to more cleavage been taken place which
results in the increase in the absorbance o f the His-tag cleaved SH2 domain on the
electropherogram.
SH2 domains belong to the OH-/3 structure class. The three-dimensional structures
o f all known SH2 domains are similar; having a large anti-parallel /3 sheet flanked by two
a helices on either side (Kuriyan and Cowbum, 1993, 1997). The CD spectra o f oft/3
proteins typically show two minima, around 208-210 nm and 220 nm, and one maximum
around 190-195 nm (Greenfield, N.J., 1996). The far-UV CD spectrum o f the tensin SH2
domain at pH 7.8 has minima at 208 nm and 220 nm and a maximum at 195 nm. The
minima are attributable to helical structure (Daffom et al., 2004). The figure also shows
the SH2 domain in 6 M guanidine. There is evidence for some residual structure. The
SH2 domain spectrum in 6 M guanidine looks less like a random coil than the tensin-C2
domain spectrum, apparently indicating that the thermostability o f the SH2 domain is
greater than that o f the C2 domain.
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The far-UV CD spectrum o f tensin-SH2 domain at pH 7.8 is similar to STAT3SH2 domain (Haan et al., 1998) and Btk SH2 domain (Tzeng et al., 2000) obtained at
physiological pH. The common feature o f all the spectra is a shoulder at 220 nm and
minima at 208-210 nm which are attributable to helical structures; which implies that
tensin-SH2 domain is also a part o f a +/3 structure class like other SH2 domains. The farUV CD spectrum o f the STAT3-SH2 domain retains its secondary structure at pH 4.5;
however tensin-SH2 domain unfolds atleast partially at pH 2.0 losing the secondary
structure. As the pH decreases, there is a change in the net ionization state o f acidic side
chains which results in a net increase in the charge on the surface o f the protein. So at
low pH values, the positive charges repel each other by electrostatic interactions and this
destabilizes the folded conformation o f the protein.
Figure 4.1 shows the structure o f two SH2 domain templates and the tensin model
colored by secondary structure. Table 4.1 gives the quantitative measurement o f the
structures. RMSD o f backbone between reference proteins and tensin model are
calculated, the highest value is 1.64 A (between 1D4W and 1P13), still low and thereby
close to average protein structure characterization. Figure 4.1 shows that the SLAM, Src,
and tensin-SH2 domain have one large anti-parallel /3-sheet, flanked by two a-helices on
either side o f it (Zhao, 2006).
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1D4W

Tensin

Figure 4.1. Ribbon Diagram o f SH2 domain o f 1D4W, 1P13 and Tensin. Red, a-helix;
Blue, /3-sheets; Green, Turns; White, Irregular Structure.

Table 4.1. RMSD o f backbone between reference proteins and tensin in A.

1D4W

1D4W
-

1LKK
0.85

1P13
1.64

1LKK

-

-

1.42

1P13

-

-

-

Tensin

0.95

0.56

0.55

The far-UV spectra o f SH2 domain at pH 12 show a shift in the minima from 210
to 205 nm but retain most o f the secondary structure. SH2 domain has a p i o f 9.15; it
being a basic protein it was not entirely surprising that it retains its secondary structure at
a high pH value in the basic range. The far-UV CD spectra at pH 2.0 closely resembles
that o f a typical random coil; indicating that the protein loses all or most o f its secondary
structure in the acidic pH range. The far-UV spectra o f the protein at pH 2.0 upon
changing its pH to 7.8 reveals a shoulder at 220 nm and a minima at 205 nm typical o f
cH/3 proteins. This data indicate that the SH2 protein folding-unfolding process on change
in pH value is reversible.
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The SH2 domain with His tag consists o f 150 amino acid residues, and the
calculated p / is 9.15. The experimental pH o f 7.8 was chosen for a positive net charge
and solubility. There are ten aromatic residues in this domain: five Phe, one Trp, and
four Tyr. The spectra o f both domains indicate aromatic asymmetry and thereby indicate
that at least some o f the molecules are folded or partly folded under the conditions o f data
collection.
The calculated molecular mass o f SH2 domain is 16734 da. Mass spectrometry
analysis revealed a mass o f 16757 da. The difference o f 23 da can be attributed to a
sodium ion whose molecular mass is exactly 23 da being bound to the protein during one
o f the several dialysis steps done to get rid o f excess salt from the purified protein.
Chemical denaturation o f the domains was monitored by measuring the change in
ellipticity at 220 nm on increasing the concentration o f GdnHCl. Ellipticity at 220 nm as
a function o f guanidine concentration is shown for SH2 domain. For comparison, the
midpoint concentration o f guanidine denaturation o f the Btk SH2 domain is 2.2 M (Tzeng
et al., 2000), while that o f the STAT3 SH2 domain is 1.7 M (Haan et al., 1999). The
denaturation temperatures as determined by change in ellipticity at 222 nm are 56 °C for
the Btk SH2 domain (Tzeng et al., 2000), 57 °C for the p85 PI-3 kinase SH2 domain
(Williams and Shoelson, 1993) and 43 °C for the STAT3 SH2 domain (Haan et al.,
1999). The midpoint concentration o f guanidine denaturation for SH2 domain is
approximately 3 M, which is significantly higher than other known SH2 domains
indicating that tensin-SH2 domain is highly thermostable.
As seen in the calorimetric profile o f SH2 domain, the heat absorption peak rises
somewhat gradually at first, the maximum occurs around 105 °C, and the peak falls
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sharply. The transition temperature is high and can probably be attributed at least in part
to a relatively small heat capacity change on denaturation: the SH2 module is small, and
the increase in heat capacity is correspondingly small, broadening the AG versus T curve,
decreasing the cold denaturation temperature, and increasing the heat denaturation
temperature.

The heat capacity profile resembles that displayed by other proteins

(Biswas and Kayastha, 2002).

There was no evident precipitation after heating the

protein to 125 °C. Nevertheless, some aggregation may have occurred on unfolding.
There was no endothermic peak in a subsequent scan o f the sample (data not shown)
indicating that unfolding was irreversible under the conditions o f the experiment.
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CHAPTER 5
CONCLUSIONS AND FUTURE WORK
Optimal expression level was achieved for tensin-SH2 domain using E. coli as a
host organism. The protein was soluble and stable; as is evident from the near-UV CD
and DSC studies. The SH2 domain folds into a compact structure on its own; without the
need for upstream or downstream domains o f tensin. Electropherogram showed the
protein to be o f high purity; which should be able to crystallize without much difficulty.
Conditions can be seeked for growing crystals o f the tensin-SH2 domain (>0.1 mm in its
smallest dimension) so that the long-range order will be sufficient to yield an atomic
resolution structure. Crystal Screen Kits can be purchased from Hampton Research for
this purpose. Initial crystallization conditions o f tensin-SH2 domain will be sought using
these kits, testing a wide range o f recombinant protein concentration, pH, salt
concentrations, and precipitants. When crystals are obtained, information from Crystal
Screen will be used to optimize crystallization conditions to produce crystals suitable for
X-ray diffraction analysis. X-ray diffraction experiments can eventually be done at the
Center for Advanced Microstructures and Devices (CAMD), LSU, Baton Rouge or
Brookhaven National Laboratory (BNL), Upton, New York.
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The chemical and heat denaturation studies show that the tensin-SH2 domain is
highly thermostable; much more than some other known SH2 domains. Characterization
o f thermodynamics o f binding can be done using Isothermal titration calorimetry.
Purified human tensin-SH2 domain can be used to raise antibodies in rabbits. Then the
antibodies can be tested for cross-reactivity with mouse tensin. Further the antibodies
can be used to label focal adhesions in cultured mouse cells. Focal adhesions are a
marker o f cell attachment. More detailed knowledge o f the structure and function o f
tensin will accelerate acquisition o f more detailed knowledge o f other focal adhesion
components, advancing the development o f molecular models o f cell attachment and
migration. Such knowledge is o f interest tobasic science as well as medicine. Moreover,
it could also provide a model for nanotechnology development, providing inspiration for
the design o f novel types o f molecular recognition and functionality, and materials design
and fabrication.
Although biomimetic nanotechnology is in its infancy, with no applications yet
reaching commercialization, the barriers in some cases lie mainly in scaling up
production processes to industrial levels. Dropping in scale from hundreds o f nanometers
to 10 nm brings researchers to the realm o f large molecules. Organisms build structures
with proteins, so a second major biomimetic approach uses natural or designed
recombinant proteins to create nanostructures. For one thing, naturally occuring proteins
can form repetitive, crystalline structures to serve as substrates for arrays o f
nanomachines or for nanoelectronics. Other researchers are experimenting with proteins
in a far more complex way; using their ability to specifically bind with each other and
with inorganic materials as a way to build new materials. One o f the characteristics o f
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biologically produced nonliving materials, such as abalone shell and spider silk, is a
hierarchical structure. That is, structures exist not just at the macroscopic level and the
crystalline level, but at many scales in between. This structuring often imparts remarkable
characteristics to a material, such as silk’s great strength. If researchers can design
appropriate new proteins, they could be used to produce similarly complex artificial
materials in an industrial process. Protein-based techniques are at an intermediate stage;
neither entirely a pure research subject, nor one verging on commercial application. For
the most part, these techniques aim at using biologically based processes to produce
artificial structures that could, in principle, be built by entirely inorganic means.
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